Results 171 to 180 of about 15,083 (218)

Unbiased high-throughput screening of drug-repurposing libraries identifies small-molecule inhibitors of clot retraction. [PDF]

open access: yesBlood Adv
Buitrago L   +7 more
europepmc   +1 more source

C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies. [PDF]

open access: yesKidney Med
Mashayekhi M   +10 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3

Journal of Immunological Methods, 2010
There is a general need for markers of systemic inflammation in acute or chronic diseases, where complement activation is involved. Available methods to monitor complement activation are elaborate and of low sensitivity; they include haemolytic assays (CH50), quantification of fluid phase terminal complex (C5b-C9) and quantification of complement split
Yaseelan Palarasah
exaly   +5 more sources

Total salivary IgA, serum C3c and IgA in obese school children

Journal of Nutritional Biochemistry, 2002
Studies of the immunologic function in adult obese humans and experimental models indicate that excess adiposity is associated with impairments in host defense mechanisms. The aim of this work was to analyze the secretory and humoral immune system in obese children (n = 105, 55 boys, 50 girls ), between 6 and 13 years of age.
Anabel Pallaro
exaly   +3 more sources

Production of antibody against C3c epitopes which are inaccessible on native C3

Journal of Immunological Methods, 1983
Anti-C3c antiserum was induced by immunizing rabbits with autologous erythrocytes coated with human C3b/C3bi. By absorption with human plasma this antiserum was rendered specific for C3c epitopes which are not expressed on native C3. This specificity may be analogous to that of immunoconglutinin.
Hansen, O   +3 more
exaly   +4 more sources

Circulating complement (C3),C3c and immune complexes in ABPA patients

Serodiagnosis and Immunotherapy in Infectious Disease, 1990
Abstract Complement (C3), its split product (C3c), CRP and circulating immune complexes were studied in 10 patients with allergic bronchopulmonary aspergillosis (ABPA) and compared with 10 age and sex matched controls. An insignificant decrease and significant increase in the levels of C3 and C3c, respectively, was observed in ABPA patients in ...
Banani Banerjee
exaly   +2 more sources

Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson’s disease

Biochemical and Biophysical Research Communications, 2006
We have used quantitative 2D gel electrophoresis to analyze serum proteins from 422 patients with neurodegenerative diseases and normal individuals in an unbiased approach to identify biomarkers. Differences in abnormal serum levels were found between amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and related disorders for 34 protein ...
Albert A Yen
exaly   +3 more sources

Hypercatabolism of Complement in Crohn's Disease—Assessment of Circulating C3c

open access: closedActa Medica Scandinavica, 1983
ABSTRACT. Split products from the main complement component 3 (C3) were investigated in untreated outpatients, 20 with Crohn's disease and 20 with ulcerative colitis. The median plasma concentration of c split product of C3 (C3c) in normals was 2 mg·l‐1, in patients with Crohn's disease 20 mg·l‐1 and in patients with ulcerative colitis 3 mg·l‐1.
J Elmgreen   +2 more
openalex   +3 more sources

Home - About - Disclaimer - Privacy